The beneficial role of the synthetic microneurotrophin BNN20 in a focal demyelination model
- 13 February 2021
- journal article
- research article
- Published by Wiley in Journal of Neuroscience Research
- Vol. 99 (5) , 1474-1495
Abstract
BNN20, a C17‐spiroepoxy derivative of the neurosteroid dehydroepiandrosterone, has been shown to exhibit strong neuroprotective properties but its role in glial populations has not been assessed. Our aim was to investigate the effect of BNN20 on glial populations by using in vitro and in vivo approaches, taking advantage of the well‐established lysophosphatidylcholine (LPC)‐induced focal demyelination mouse model. Our in vivo studies, performed in male mice, showed that BNN20 treatment leads to an increased number of mature oligodendrocytes (OLs) in this model. It diminishes astrocytic accumulation during the demyelination phase leading to a faster remyelination process, while it does not affect oligodendrocyte precursor cell recruitment or microglia/macrophage accumulation. Additionally, our in vitro studies showed that BNN20 acts directly to OLs and enhances their maturation even after they were treated with LPC. This beneficial effect of BNN20 is mediated, primarily, through the neurotrophin receptor TrkA. In addition, BNN20 reduces microglial activation and their transition to their pro‐inflammatory state upon lipopolysaccharides stimulation in vitro. Taken together our results suggest that BNN20 could serve as an important molecule to develop blood–brain barrier‐permeable synthetic agonists of neurotrophin receptors that could reduce inflammation, protect and increase the number of functional OLs by promoting their differentiation/maturation.Keywords
Funding Information
- State Scholarships Foundation
This publication has 84 references indexed in Scilit:
- Neurosteroid Dehydroepiandrosterone Interacts with Nerve Growth Factor (NGF) Receptors, Preventing Neuronal ApoptosisPLOS Biology, 2011
- Functions of Astrocytes and their Potential As Therapeutic TargetsNeurotherapeutics, 2010
- Restoring the balance between disease and repair in multiple sclerosis: insights from mouse modelsDisease Models & Mechanisms, 2010
- Astrocytes: biology and pathologyActa Neuropathologica, 2009
- Heterogeneity of Microglial Activation in the Innate Immune Response in the BrainJournal of Neuroimmune Pharmacology, 2009
- Neurobiological and neuropsychiatric effects of dehydroepiandrosterone (DHEA) and DHEA sulfate (DHEAS)Frontiers in Neuroendocrinology, 2009
- Neurosteroid regulation of central nervous system developmentPharmacology & Therapeutics, 2007
- Multiple sclerosis: a complicated picture of autoimmunityNature Immunology, 2007
- Monocyte and macrophage heterogeneityNature Reviews Immunology, 2005
- Preparation of separate astroglial and oligodendroglial cell cultures from rat cerebral tissue.Journal of Cell Biology, 1980